newsfilter
← Latest News
GlobeNewswire·

Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors

WALTHAM, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (NASDAQ:ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, annou